Cancer statistics, 2024
2024/01/01 by Rebecca L. Siegel, Angela N. Giaquinto, Ahmedin Jemal · 112 citations
Medicine · #Cervical Cancer and HPV Research #Colorectal Cancer Screening and Detection #Global Cancer Incidence and Screening
paper · pdf · doi:10.3322/caac.21820
openalex publication_date 2024/01/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/31
Abstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries (through 2020) and mortality data collected by the National Center for Health Statistics (through 2021). In 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both the adjuvant and metastatic settings. However, these gains are threatened by increasing incidence for 6 of the top 10 cancers. Incidence rates increased during 2015-2019 by 0.6%-1% annually for breast, pancreas, and uterine corpus cancers and by 2%-3% annually for prostate, liver (female), kidney, and human papillomavirus-associated oral cancers and for melanoma. Incidence rates also increased by 1%-2% annually for cervical (ages 30-44 years) and colorectal cancers (ages <55 years) in young adults. Colorectal cancer was the fourth-leading cause of cancer death in both men and women younger than 50 years in the late-1990s but is now first in men and second in women. Progress is also hampered by wide persistent cancer disparities; compared to White people, mortality rates are two-fold higher for prostate, stomach and uterine corpus cancers in Black people and for liver, stomach, and kidney cancers in Native American people. Continued national progress will require increased investment in cancer prevention and access to equitable treatment, especially among American Indian and Alaska Native and Black individuals.
Cited by
- Inhibiting Pink1/Parkin-mediated mitophagy enhances the anticancer effects of quercetin in hepatocellular carcinomaf
- Histone lactylation-driven feedback loop modulates cholesterol-linked immunosuppression in pancreatic cancer
- Breast cancer statistics 2024
- Dexrazoxane protects against doxorubicin‐induced cardiotoxicity in susceptible human living myocardial slices: A proof‐of‐concept study
- Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians
- Biologically responsive and structure-tunable 1H/19F MRI nanoprobes: personalizing cancer imaging and therapy
- Ageing, immune fitness and cancer
- Ultraprocessed food intake and postmenopausal breast cancer risk in the NIH-AARP Diet and Health Study
- Nuclear envelope proteins, mechanotransduction, and their contribution to breast cancer progression
- “Nailing down” risk and improving outcomes in early-stage breast cancer
- SMAD4 Deficiency Promotes Pancreatic Cancer Progression and Confers Susceptibility to TGFβ Inhibition
- Plasminogen activator inhibitors orchestrate the immunosuppressive tumor microenvironment in pancreatic cancer
- UltraLBM-UNet: Ultralight Bidirectional Mamba-based Model for Skin Lesion Segmentation
- Pancreatic cancer cachexia is mediated by PTHrP-driven disruption of adipose <i>de novo</i> lipogenesis
- A Triple Threat Against Ovarian Cancer: Os(II)‐Pt(IV)‐Ceritinib Conjugates for Photodynamic Therapy, Chemotherapy, and Immunogenic Cell Death Induction
- Submanifold Sparse Convolutional Networks for Automated 3D Segmentation of Kidneys and Kidney Tumours in Computed Tomography
- The Warburg hypothesis and the emergence of the mitochondrial metabolic theory of cancer
- Multi-omic markers of intraductal papillary mucinous neoplasms progression into pancreatic cancer
- The tumour histopathology “glossary” for AI developers
- Characterization of the immune landscape in healthy mouse prostate and during prostate cancer progression
- Aged and <i>BRCA</i> -Mutated Stromal Cells Drive Epithelial Cell Transformation
- Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival
- Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients
- Adnexal Lesion Discrimination Using Deep Learning Analysis of Dynamic Contrast-enhanced US Images
- PIWIL2 downregulation in colon cancer promotes transposon activity and pro-tumorigenic phenotypes
- Trends in Cancer Incidence and Mortality Rates in Early-Onset and Older-Onset Age Groups in the United States, 2010–2019
- The ethyl acetate extract of Schefflera kwangsiensis ameliorates oxaliplatin-induced peripheral neuropathic pain via SERCA2b
- Cancer-on-a-chip for precision cancer medicine
- Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
- A Zirconium Aza-BODIPY Derivative as a Near-Infrared Fluorescent/Photoacoustic Imaging Bimodal Probe
- Spatial Clustering of Recently Activated Cytotoxic Lymphocytes Improves Association with Overall Survival in Women with High-Grade Serous Ovarian Cancer
- Oncogenic KRAS/ERK/JUNB signaling suppresses differentiation regulator GATA6 in pancreatic cancer
- Large multicenter validation of urine RNA profile for urothelial carcinoma detection and surveillance
- A population-level analysis on the association of cannabis use and urologic cancers
- Moving Light Adaptive Colonoscopy Reconstruction via Illumination-Attenuation-Aware 3D Gaussian Splatting
- Anatomically resectable <i>versus</i> biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness
- <i>AACR Cancer Progress Report 2024</i>: Inspiring Science—Fueling Progress—Revolutionizing Care
- Luteolin induces oxidative stress and apoptosis via dysregulating the cytoprotective Nrf2-Keap1-Cul3 redox signaling in metastatic castration-resistant prostate cancer cells
- Stress Management Program for Scanxiety in People With Advanced Lung Cancer: Intervention Adaptation and Stakeholder Feedback
- Delta 4-desaturase sphingolipid 2 enhances prostate cancer stem-like traits through phytoceramide-mediated PI3K-AKT signaling pathway
- From black box to clarity: Strategies for effective AI informed consent in healthcare
- Development and Validation of a Deep Learning–enabled Single Breath-hold Abbreviated MRI Protocol for Hepatocellular Carcinoma Diagnosis
- Curriculum Learning with Synthetic Data for Enhanced Pulmonary Nodule Detection in Chest Radiographs
- Aging represses oncogenic KRAS-driven lung tumorigenesis and alters tumor suppression
- Evaluating Temperature Scaling Calibration Effectiveness for CNNs under Varying Noise Levels in Brain Tumour Detection
- Colorectal cancer molecular profiling: Opportunities for early detection
- Cancer Heterogeneity and Plasticity— A new journal dedicated to understanding cancer cell states and interactions with the tumor microenvironment
- Advanced imaging and management of superior vena cava syndrome
- PVTAdpNet: Polyp Segmentation using Pyramid vision transformer with a novel Adapter block
- Improving the health literacy of women with breast cancer using an old–new approach: A feasibility study
- Acquired resistance in cancer: towards targeted therapeutic strategies
- Combination of cerium oxide nanoparticles and antimalarial drug chloroquine: characterization and anti-cancer potential for triple negative breast cancer
- Interlacing biology and engineering: An introduction to textiles and their application in tissue engineering
- Civic engagement and breast cancer screening participation among US citizens
- Chemotherapy switch for localized pancreatic cancer: a systematic review and meta-analysis
- Racial, Ethnic, and Socioeconomic Survival Disparities in Early-Onset Metastatic Colorectal Cancer
- Analyzing Patient Characteristics and Lung Cancer Outcomes Pre and Post the 2021 USPSTF Lung Cancer Screening Guidelines
- Preclinical safety assessment and immunological evaluation of xenogeneic mammary cells of porcine origin, utilized as an intralesional immunotherapeutic agent
- DNA Methylation in Blood Samples from Malignant Mammary Tumors of Companion Dogs: A Pilot Study
- Determinants of pancreatic tropism in metastatic renal cell carcinoma
- A NIR light activated self‐reporting carbon dots assembly as phototheranostics for tumor photodynamic therapy
- Treatment-induced stemness and lineage plasticity in driving prostate cancer therapy resistance
- Dual blockade of PD-1 and NKG2A prevents NK cell senescence and reprograms the immunosuppressive microenvironment in pancreatic cancer
- The bibliometric analysis of documents concerning the relationship between the microbiota and urological malignancies
- DNA-PKcs inhibition as a therapeutic approach for differentiated thyroid cancer
- Insights into the Structural Patterns in Human Glioblastoma Cell Line SF268 Activity and ADMET Prediction of Curcumin Derivatives
- The tumor-sentinel lymph node immuno-migratome reveals CCR7⁺ dendritic cells drive response to sequenced immunoradiotherapy
- Epigenetic mechanisms underlying endometrial cancer outcomes: race-specific patterns of DNA methylation associated with molecular subtypes and survival
- TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stress
- The Rochester Protocol for living donor liver transplantation of unresectable colorectal liver metastasis: A 5-year report on selection, approval, and outcomes
- Global lung cancer burden attributable to air fine particulate matter and tobacco smoke exposure: spatiotemporal patterns, sociodemographic characteristics, and transnational inequalities from 1990 to 2021
- Pan-cancer analysis of Methyltransferase-like 16 (METTL16) and validated in colorectal cancer
- Nuclear Focal Adhesion Kinase Protects against Cisplatin Stress in Ovarian Carcinoma
- NF2 loss malignantly transforms human pancreatic acinar cells and enhances cell fitness under environmental stress
- Neighborhood-level disadvantage and lifestyle-based supportive care in head and neck cancer: insights from the Midwestern United States
- Targeting conserved domains of hypoxia-inducible factors for cancer therapy
- A Systematic Review on Leveraging Artificial Intelligence for Pancreatic Cancer Diagnosis: Review
- LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in <i>LKB1</i> -Mutant Lung Cancer
- A Mitochondrial DNA‐Releasing Photosensitizer Potentiates Innate Immunity for Tumor Eradication and Prevention
- EMeRALDS: Electronic Medical Record Driven Automated Lung Nodule Detection and Classification in Thoracic CT Images
- Retrieval-Augmented VLMs for Multimodal Melanoma Diagnosis
- Multi-Scale Deep Learning for Colon Histopathology: A Hybrid Graph-Transformer Approach
- Clofazimine inhibits small-cell lung cancer progression by modulating the kynurenine/aryl hydrocarbon receptor axis
- DoSReMC: Domain Shift Resilient Mammography Classification using Batch Normalization Adaptation
- Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma
- Targeted nanoparticle delivery of irinotecan enhances tumor response to PD-L1 blockade in colorectal cancer
- Towards Affordable Tumor Segmentation and Visualization for 3D Breast MRI Using SAM2
- Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer. [europepmc]
- Mechanical properties of human tumour tissues and their implications for cancer development. [europepmc]
- Aging and cancer. [europepmc]
- Lung Cancer Screening in the US, 2022. [europepmc]
- Botensilimab plus balstilimab in relapsed/refractory microsatellite stable metastatic colorectal cancer: a phase 1 trial. [europepmc]
- Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management. [europepmc]
- Cancer stem cells: advances in knowledge and implications for cancer therapy. [europepmc]
- Cancer, metastasis, and the epigenome. [europepmc]
- LncRNA-encoded peptides in cancer. [europepmc]
- Identification of the novel exhausted T cell CD8 + markers in breast cancer. [europepmc]
- Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the Global Burden of Disease Study 2021. [europepmc]
- Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial. [europepmc]
- Intermetallics triggering pyroptosis and disulfidptosis in cancer cells promote anti-tumor immunity. [europepmc]
- Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-Analysis. [europepmc]
- Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer. [europepmc]
- Comparative analysis of cancer statistics in China and the United States in 2024. [europepmc]
- Recent Patterns and Trends in Global Prostate Cancer Incidence and Mortality: An Update. [europepmc]
- Roles of human papillomavirus in cancers: oncogenic mechanisms and clinical use. [europepmc]
- Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines. [europepmc]
- Hepatocellular carcinoma: signaling pathways and therapeutic advances. [europepmc]
- Breast cancer: pathogenesis and treatments. [europepmc]
- Traditional Chinese medicine in lung cancer treatment. [europepmc]
- Projected Lifetime Cancer Risks From Current Computed Tomography Imaging. [europepmc]
- Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians. [europepmc]
- Global burden of female breast cancer: new estimates in 2022, temporal trend and future projections up to 2050 based on the latest release from GLOBOCAN. [europepmc]
Related